GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Days Payable

Biomics Biopharma (ASX:BBM) Days Payable : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Days Payable?

Biomics Biopharma's average Accounts Payable for the six months ended in . 20 was A$0.00 Mil. Biomics Biopharma's Cost of Goods Sold for the six months ended in . 20 was A$0.00 Mil.

The historical rank and industry rank for Biomics Biopharma's Days Payable or its related term are showing as below:

ASX:BBM's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 148.28
* Ranked among companies with meaningful Days Payable only.

Biomics Biopharma's Days Payable stayed the same from . 20 (0.00) to . 20 (0.00).


Biomics Biopharma Days Payable Historical Data

The historical data trend for Biomics Biopharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Days Payable Chart

Biomics Biopharma Annual Data
Trend
Days Payable

Biomics Biopharma Semi-Annual Data
Days Payable

Competitive Comparison of Biomics Biopharma's Days Payable

For the Biotechnology subindustry, Biomics Biopharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomics Biopharma's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomics Biopharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Biomics Biopharma's Days Payable falls into.



Biomics Biopharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Biomics Biopharma's Days Payable for the fiscal year that ended in . 20 is calculated as

Days Payable (A: . 20 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: . 20 ) + Accounts Payable (A: . 20 )) / count ) / Cost of Goods Sold (A: . 20 )*Days in Period
=( ( + ) / 1 ) / *365
=0 / *365
=N/A

Biomics Biopharma's Days Payable for the quarter that ended in . 20 is calculated as:

Days Payable (Q: . 20 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: . 20 ) + Accounts Payable (Q: . 20 )) / count ) / Cost of Goods Sold (Q: . 20 )*Days in Period
=( ( + ) / 1 ) / *365 / 2
=0 / *365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomics Biopharma Days Payable Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomics Biopharma (ASX:BBM) Business Description

Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines